Antisense antiviral agent and method for treating ssRNA viral infection
US6828105B2 · kind B2 · utility
73Cited by
4References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2002 |
| Grant date | Dec 7, 2004 |
| Priority date | — |
| Expiry date | Oct 28, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides antisense antiviral compounds and methods of their use in inhibition of growth of viruses of the picornavirus, calicivirus, togavirus and flavivirus families, as in treatment of a viral infection. The antisense antiviral compounds are substantially uncharged oligomers having a targeting base sequence that is substantially complementary to a viral target sequence which spans the AUG start site of the first open reading frame of the viral genome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.